🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to another great Theranostics online webinar. Hope to see you there.

I am very happy to share this updated collaborative effort! PSMA-PET–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective Study sciencedirect.com/science/articl…

Excited that Dr Karina Meredith, Director of the Environment Research and Technology Group, will be speaking this evening at the celebrated #ScienceMeetsParliament dinner joining other ANSTO representatives & esteemed guests

Make sure this session is in your diary for next Monday. Another informative and interactive session on Theranostics - not to be missed.

Super proud and honored to have worked with WebsEdge - Medicine SNMMI to develop this video about our work! #molecularimaging UNC Radiology UNC-Chapel Hill youtube.com/watch?v=KO22Ly…

AANMS is excited to announce early bird registrations are now open at theranostics-course.aanms.org Don't miss this opportunity to register early.

Dave Pattison Sze Ting Lee ANZSNM Peter Mac Cancer Centre Louise Emmett Michael Hofman Karen Jones NeuroEndocrine Cancer Australia CancerCouncilOz Movember Australia Early bird registration and accommodation at conference prices both close this Friday 19 July - secure your place now ☑ theranostics-course.aanms.org.au

Dont miss this exciting Theranostics opportunity. Register now at theranostics-course.aanms.org.au

Great start on day one to our 2024 Theranostics Course. Stellar line up of international and nations expert speakers; over 250 delegates; interactive/live MDT sessions throughout the day. Dont miss day two. theranostics-course.aanms.org.au

At ⁦⁦Theranostics AANMS⁩ conference and realised how much theranostic drug development and therapy are already revolutionizing care for many diseases in adults and children ⁦Sze Ting Lee⁩ ⁦Michael Hofman⁩ ⁦Louise Emmett⁩ ⁦The Royal Australasian College of Physicians⁩

Australasian Assoc of Nuclear Medicine Specialists If you are in or near Sydney, why not hear from some amazing national and international speakers. The Saturday program can be a stand alone program for physicians. Register now.

We are pleased to announce the Launch of the Lancet Oncology Commission Report on Radiotherapy and Theranostics! Access the full paper authors.elsevier.com/c/1js3i5EIIgPe… #ANZSNM #NuclearMedicine #Theranostics

Nuclear medicine is transforming healthcare, from cancer treatment to Alzheimer’s breakthroughs. We celebrate the physicians, technologists & scientists behind these innovations. Proud to be part of this field at Isotopia, dedicated to advancing its life-saving potential.

A triple-tracer imaging strategy can be exploited to detect intrapatient intermetastatic heterogeneity, helping to guide biopsy and personalize management of advanced #ProstateCancer. ow.ly/8UmV50Txx8o #NuclearMedicine #PETscan

16 Australians are diagnosed with neuroendocrine cancer every single day. Mark Butler MP and Anthony Albanese, we ask respectfully that your Government respond to the recent #SenateInquiry recommendations. #NeuroendocrineCancer patients deserve equitable support and care.

Efficacy and toxicity of ¹⁷⁷Lu-PSMA-617 for mCRPC: Results from the U.S. expanded-access program and comparisons with phase 3 VISION data. ow.ly/Kc0T50TxxgR #NuclearMedicine #ProstateCancer @VMurthymed Andrei Gafita Jeremie Calais Oliver Sartor Thomas Hope

Featured in this month's JNM: A novel PET technique can visualize spinal cord injuries by detecting intact nerve connections in the injured spinal cord. Using this technique gives doctors critical information about which patients may be able to regain mobility.

Twenty cycles (that's right 20) of Lutetium-177 PSMA-617 for metastatic castration-resistant cancer!! Check our case report just published in JNM jnm.snmjournals.org/content/early/… Current randomized controlled data demonstrate the safety and efficacy of 6 cycles of

... how common is PSMA-negative significant prostate cancer? In the proPSMA study it was 3.3% Hot of the press in JNM: jnm.snmjournals.org/content/early/… Wonderful work from David Chen and team ProsTIC including James Buteau Declan Murphy

Game-changer in prostate cancer risk stratification! PSMA-PET isn’t just for staging—it predicts survival. European Urology Advanced Prostate Cancer Consensus Conference European Association of Urology (EAU) Prostate Cancer Foundation Ken Herrmann Michael Hofman doi.org/10.1016/j.euru…